Background: Commuting is essential for working life; however, prolonged travel times can negatively affect health, particularly musculoskeletal pain. This study aims to examine the relationship between commuting time and musculoskeletal pain (back, upper extremity, and lower extremity pain), in the context of working time. Methods: This cross-sectional study used data from the Sixth Korean Working Conditions Survey conducted in Korea between October 2020 and April 2021. Variables such as commuting time, weekly working hours, and shift work were assessed using the survey questions. Musculoskeletal pain was determined based on self-reported pains in the previous year. The covariates included demographics, employment status, ergonomic risks, and job stress. The association between commuting time and musculoskeletal pain stratified by weekly working hours or shift work was analyzed by survey-weighted logistic regression analysis. Results: This study found a significant association between longer commuting times and increased prevalence of musculoskeletal pain, particularly back, upper extremity, and lower extremity pain. When commuting time was ≤60, 61–120, >120 minutes, the odds ratio was 1.00, 1.33 (95% confidence interval [CI]: 1.16–1.52), and 2.41 (95% CI: 1.77–3.29) for back pain; 1.00, 1.29 (95% CI: 1.13–1.46), and 2.27 (95% CI: 1.71–3.00) for upper extremity pain; and 1.00, 1.24 (95% CI: 1.05–1.45), and 1.53 (95% CI: 1.13–2.08) for lower extremity pain, respectively. Furthermore, except for upper extremity pain, this trend was amplified when participants were concurrently exposed to long working hours, and for lower extremity pain, this trend was aggravated among shift workers. Conclusions Long commuting time may be a risk factor for musculoskeletal pain, and its’ effects could be aggravated when combined with long working hours or shift work. This study observed the detrimental impact of prolonged commuting on musculoskeletal health, particularly among employees with extended working hours or shift work.

Background: Commuting is essential for working life; however, prolonged travel times can negatively affect health, particularly musculoskeletal pain. This study aims to examine the relationship between commuting time and musculoskeletal pain (back, upper extremity, and lower extremity pain), in the context of working time. Methods: This cross-sectional study used data from the Sixth Korean Working Conditions Survey conducted in Korea between October 2020 and April 2021. Variables such as commuting time, weekly working hours, and shift work were assessed using the survey questions. Musculoskeletal pain was determined based on self-reported pains in the previous year. The covariates included demographics, employment status, ergonomic risks, and job stress. The association between commuting time and musculoskeletal pain stratified by weekly working hours or shift work was analyzed by survey-weighted logistic regression analysis. Results: This study found a significant association between longer commuting times and increased prevalence of musculoskeletal pain, particularly back, upper extremity, and lower extremity pain. When commuting time was ≤60, 61–120, >120 minutes, the odds ratio was 1.00, 1.33 (95% confidence interval [CI]: 1.16–1.52), and 2.41 (95% CI: 1.77–3.29) for back pain; 1.00, 1.29 (95% CI: 1.13–1.46), and 2.27 (95% CI: 1.71–3.00) for upper extremity pain; and 1.00, 1.24 (95% CI: 1.05–1.45), and 1.53 (95% CI: 1.13–2.08) for lower extremity pain, respectively. Furthermore, except for upper extremity pain, this trend was amplified when participants were concurrently exposed to long working hours, and for lower extremity pain, this trend was aggravated among shift workers. Conclusions Long commuting time may be a risk factor for musculoskeletal pain, and its’ effects could be aggravated when combined with long working hours or shift work. This study observed the detrimental impact of prolonged commuting on musculoskeletal health, particularly among employees with extended working hours or shift work.

Background: Commuting is essential for working life; however, prolonged travel times can negatively affect health, particularly musculoskeletal pain. This study aims to examine the relationship between commuting time and musculoskeletal pain (back, upper extremity, and lower extremity pain), in the context of working time. Methods: This cross-sectional study used data from the Sixth Korean Working Conditions Survey conducted in Korea between October 2020 and April 2021. Variables such as commuting time, weekly working hours, and shift work were assessed using the survey questions. Musculoskeletal pain was determined based on self-reported pains in the previous year. The covariates included demographics, employment status, ergonomic risks, and job stress. The association between commuting time and musculoskeletal pain stratified by weekly working hours or shift work was analyzed by survey-weighted logistic regression analysis. Results: This study found a significant association between longer commuting times and increased prevalence of musculoskeletal pain, particularly back, upper extremity, and lower extremity pain. When commuting time was ≤60, 61–120, >120 minutes, the odds ratio was 1.00, 1.33 (95% confidence interval [CI]: 1.16–1.52), and 2.41 (95% CI: 1.77–3.29) for back pain; 1.00, 1.29 (95% CI: 1.13–1.46), and 2.27 (95% CI: 1.71–3.00) for upper extremity pain; and 1.00, 1.24 (95% CI: 1.05–1.45), and 1.53 (95% CI: 1.13–2.08) for lower extremity pain, respectively. Furthermore, except for upper extremity pain, this trend was amplified when participants were concurrently exposed to long working hours, and for lower extremity pain, this trend was aggravated among shift workers. Conclusions Long commuting time may be a risk factor for musculoskeletal pain, and its’ effects could be aggravated when combined with long working hours or shift work. This study observed the detrimental impact of prolonged commuting on musculoskeletal health, particularly among employees with extended working hours or shift work.

Purpose: To determine subjective symptoms and medical history of patients with intermittent exotropia in a large study population. Methods: The Korean Intermittent Exotropia Multicenter Study (KIEMS) is a nationwide, observational, cross-sectional, multicenter study conducted by the Korean Association for Pediatric Ophthalmology and Strabismus including 5,385 patients with intermittent exotropia. Subjective symptoms and medical history of patients with intermittent exotropia were extracted by a comprehensive survey based on a self-administered questionnaire according to the study protocol of the KIEMS. Results: The mean age of symptom onset was 5.5 years. The most common symptom reported in patients with intermittent exotropia was photophobia (52.1%), followed by diplopia at near fixation (7.3%) and distance fixation (6.2%). Preterm birth was found in 8.8%, and 4.1% had perinatal complications. A family history of strabismus was present in 14.9%, and 5.5% of patients had a family member who underwent strabismus surgery. Conclusions The KIEMS is one of the largest clinical studies on intermittent exotropia. Intermittent exotropia frequently caused photophobia and diplopia, and patients with a family history was not uncommon.

Objective: Dysphagia is a common clinical condition characterized by difficulty in swallowing. It is sub-classified into oropharyngeal dysphagia, which refers to problems in the mouth and pharynx, and esophageal dysphagia, which refers to problems in the esophageal body and esophagogastric junction. Dysphagia can have a significant negative impact one’s physical health and quality of life as its severity increases. Therefore, proper assessment and management of dysphagia are critical for improving swallowing function and preventing complications. Thus a guideline was developed to provide evidence-based recommendations for assessment and management in patients with dysphagia. Methods: Nineteen key questions on dysphagia were developed. These questions dealt with various aspects of problems related to dysphagia, including assessment, management, and complications. A literature search for relevant articles was conducted using Pubmed, Embase, the Cochrane Library, and one domestic database of KoreaMed, until April 2021. The level of evidence and recommendation grade were established according to the Grading of Recommendation Assessment, Development and Evaluation methodology. Results: Early screening and assessment of videofluoroscopic swallowing were recommended for assessing the presence of dysphagia. Therapeutic methods, such as tongue and pharyngeal muscle strengthening exercises and neuromuscular electrical stimulation with swallowing therapy, were effective in improving swallowing function and quality of life in patients with dysphagia. Nutritional intervention and an oral care program were also recommended. Conclusion This guideline presents recommendations for the assessment and management of patients with oropharyngeal dysphagia, including rehabilitative strategies.

Purpose: Since tumor mutational burden (TMB) and gene expression profiling (GEP) have complementary effects, they may have improved predictive power when used in combination. Here, we investigated the ability of TMB and GEP to predict the immunotherapy response in patients with non–small cell lung cancer (NSCLC) and assessed if this combination can improve predictive power compared to that when used individually. Materials and Methods: This retrospective cohort study included 30 patients with NSCLC who received immune checkpoint inhibitors (ICI) therapy at the Seoul National University Bundang Hospital. programmed cell death-ligand-1 (PD-L1) protein expression was assessed using immunohistochemistry, and TMB was measured by targeted deep sequencing. Gene expression was determined using NanoString nCounter analysis for the PanCancer IO360 panel, and enrichment analysis were performed. Results: Eleven patients (36.7%) showed a durable clinical benefit (DCB), whereas 19 (63.3%) showed no durable benefit (NDB). TMB and enrichment scores (ES) showed significant differences between the DCB and NDB groups (p=0.044 and p=0.017, respectively); however, no significant correlations were observed among TMB, ES, and PD-L1. ES was the best single biomarker for predicting DCB (area under the curve [AUC], 0.794), followed by TMB (AUC, 0.679) and PD-L1 (AUC, 0.622). TMB and ES showed the highest AUC (0.837) among other combinations (AUC [TMB and PD-L1], 0.777; AUC [PD-L1 and ES], 0.763) and was similar to that of all biomarkers used together (0.832). Conclusion The combination of TMB and ES may be an effective predictive tool to identify patients with NSCLC patients who would possibly benefit from ICI therapies.

BACKGROUND/AIMS: An association between obesity and erosive esophagitis has been reported, but the effects of sarcopenia and obesity on erosive esophagitis are unknown. This study examined the relationship between obesity, sarcopenia, sarcopenic obesity, and erosive esophagitis in a large population of asymptomatic men and women.METHODS: This study analyzed 32,762 subjects who underwent a comprehensive health check-up, which included upper gastrointestinal endoscopy, from August 2006 to December 2011 by a cross-sectional study. Sarcopenia was defined as a decrease in the appendicular skeletal muscle mass (ASM)/body weight value of two SD or more below the normal means for a younger reference group.RESULTS: The study was carried out on four groups according to obesity and sarcopenic status: normal, obesity, sarcopenic, and sarcopenic obese group. In a multivariable model, the risk of erosive esophagitis was higher in the obese (adjusted OR [aOR] 1.35, 95% CI 1.22–1.49), sarcopenic (aOR 2.12, 95% CI 1.40–3.19), and sarcopenic obese groups (aOR 1.54, 95% CI 1.27–1.87) than in the normal group. The risk of erosive esophagitis was higher in the sarcopenic and sarcopenic obese groups than the obese group; the ORs were 1.63 (95% CI 1.08–2.47) and 1.22 (95% CI 1.01–1.46), respectively. In dose-response analysis, increasing sarcopenia severity showed a positive and graded relationship with the overall, Los Angeles (LA)-B or higher grade, and LA-C erosive esophagitis.CONCLUSIONS: This study suggests that sarcopenia is strongly and progressively associated with erosive esophagitis.

BACKGROUND/AIMS: Patients with chronic kidney disease (CKD) have a high risk of gastrointestinal tract bleeding because of platelet dysfunction attributable to uremia, a poor blood supply, and frequent use of anticoagulant agents. We describe the colonoscopic characteristics of lower gastrointestinal tract bleeding (LGIB) in patients with CKD. METHODS: A total of 230 hospitalized patients with CKD who underwent colonoscopy because of suspected LGIB between January 2003 and August 2016 were reviewed retrospectively. We categorized CKD into five stages according to the estimated glomerular filtration rate and compared the colonoscopic findings and clinical manifestations among these five subgroups. RESULTS: Of the 230 patients with CKD suspected of LGIB, 73 (31.7%, 103 cases) were colonoscopically confirmed to exhibit LGIB. Their mean age was 65.7 ± 12.8 years, and 52.1% were female (n = 38). The most common causes of LGIB were hemorrhoidal bleeding (32 cases, 43.8%), followed by bleeding of colorectal ulcers (21 cases, 28.8%), diverticular bleeding (12 cases, 16.4%), colitis-related bleeding (12 cases, 16.4%), and angiodysplastic bleeding (12 cases, 16.4%). As the CKD stage progressed, the incidence of LGIB increased (p = 0.043). On multivariate logistic regression analysis, LGIB was more common in CKD patients with hemorrhoids (odds ratio [OR]: 4.349, 95% confidence interval [CI]: 2.043–9.256, p < 0.001) or colorectal ulcers (OR: 20.001, 95% CI: 4.780–83.686, p ℃ 0.001) and in those on hemodialysis (OR: 6.863, 95% CI: 1.140–41.308, p = 0.035). CONCLUSIONS In CKD patients, the risk of LGIB is significantly increased by hemorrhoids, colorectal ulcers, and a positive hemodialysis status.

BACKGROUND/AIMS: Patients with chronic kidney disease (CKD) have a high risk of gastrointestinal tract bleeding because of platelet dysfunction attributable to uremia, a poor blood supply, and frequent use of anticoagulant agents. We describe the colonoscopic characteristics of lower gastrointestinal tract bleeding (LGIB) in patients with CKD. METHODS: A total of 230 hospitalized patients with CKD who underwent colonoscopy because of suspected LGIB between January 2003 and August 2016 were reviewed retrospectively. We categorized CKD into five stages according to the estimated glomerular filtration rate and compared the colonoscopic findings and clinical manifestations among these five subgroups. RESULTS: Of the 230 patients with CKD suspected of LGIB, 73 (31.7%, 103 cases) were colonoscopically confirmed to exhibit LGIB. Their mean age was 65.7 ± 12.8 years, and 52.1% were female (n = 38). The most common causes of LGIB were hemorrhoidal bleeding (32 cases, 43.8%), followed by bleeding of colorectal ulcers (21 cases, 28.8%), diverticular bleeding (12 cases, 16.4%), colitis-related bleeding (12 cases, 16.4%), and angiodysplastic bleeding (12 cases, 16.4%). As the CKD stage progressed, the incidence of LGIB increased (p = 0.043). On multivariate logistic regression analysis, LGIB was more common in CKD patients with hemorrhoids (odds ratio [OR]: 4.349, 95% confidence interval [CI]: 2.043–9.256, p < 0.001) or colorectal ulcers (OR: 20.001, 95% CI: 4.780–83.686, p ℃ 0.001) and in those on hemodialysis (OR: 6.863, 95% CI: 1.140–41.308, p = 0.035). CONCLUSIONS: In CKD patients, the risk of LGIB is significantly increased by hemorrhoids, colorectal ulcers, and a positive hemodialysis status.
Anticoagulants ; Blood Platelets ; Colonoscopy ; Female ; Gastrointestinal Tract ; Glomerular Filtration Rate ; Hemorrhage ; Hemorrhoids ; Humans ; Incidence ; Logistic Models ; Lower Gastrointestinal Tract ; Renal Dialysis ; Renal Insufficiency, Chronic ; Retrospective Studies ; Ulcer ; Uremia